HONOLULU -- As suspected, patients with acute respiratory distress syndrome (ARDS) had particularly bad outcomes if they had coexisting pulmonary hypertension (PH), an analysis of the National ...

Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in critical care.

The incidence of ARDS in patients with severe acute pancreatitis is about 36%, with age (older than 50 years) and female sex as key risk factors.

I would like your opinion on the role of corticosteroids in early and late ARDS. When should I institute steroids in my patient with ARDS? The complexities of the ARDSnet study and the variation seen ...

Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight The ARSD clinical trial analysis report delivers important ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...